Autoimmune Presentation Rhupus Like of lung cancer non-small cells
DOI:
https://doi.org/10.52076/eacad-v3i2.168Keywords:
Rheumatoid Arthritis; Lupus; Autoimmunity.Abstract
Introduction: Rhupus, or Rhupus Syndrome, is a rare rheumatologic disease characterized by the overlapping of Systemic Lupus Erythematosus and Rheumatoid Arthritis in patients meeting SLICC and ACR/EULAR criteria. Objective: To describe the clinical case of a patient with non-small cell lung cancer presenting with Rhupus Syndrome and to review the literature on Rhupus and its clinical features. Methodology: Case report type of study descriptive qualitative with information obtained directly from the medical records kept during hospitalization. Discussion: Rhupus Syndrome, characterized by the overlapping of SLE and RA, has two most common presentations, the first are patients who begin with RA, and then are diagnosed with SLE, comprising 2/3 of the cases of Rhupus. The second presentation consists of patients initially with SLE or with both diseases diagnosed at the beginning. As this is a rare syndrome, there are no validated diagnostic criteria for this disease. Conclusion: Although the interposition of rheumatologic diseases is not rare, Rhupus has an estimated prevalence of 0.09% of the population. Diagnosis may be difficult because there are no well-defined diagnostic criteria and because of its rarity; however, this diagnosis may be determinant for an adequate approach to the patient and a better prognosis, reducing complications related to SLE and/or RA.
References
ANTONIHGNI, Luca, et al. Rhupus: a systematic literature review. Autoimmunity Reviews, p. 102-612, 2020.
AZMECUA-GUERRA, LM. Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion?. J. Rheumatol; 36:4-6, 2009.
BRITO, Tayra H G; et al. Relato de Caso–Síndrome de RUPHUS: uma excepcionalidade diagnostica. Brazilian Journal of Health Review, v. 4, n. 2, p. 6714-6719, 2021.
DANION, François et al. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients. Rheumatic and Musculoskeletal Diseases, v. 3, n. 2, p. e000555, 2017.
LI, Jing et al. Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case–control study. Medicine (Baltimore), v. 93, n. 10, 2014.
LIU, T et al. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus; 23:958-63, 2014.
SIMON, T.A, et al. Prevalence of co- existing autoimmune disease in rheumatoid arthritis: a cross-sectional study. Adv Ther; 34:2481–90, 2017.
SOLIS CARTAS, Urbano et al. Rhupus syndrome. A rare combination. Revista Colombiana de Reumatología, v. 24, n. 4, p. 237-241, 2017.
WALLACE, Daniel J. et al. Dubois’ lupus erythematosus and related syndromes. 8th edition. Pg 543-544, 2013.
ZIEGELASCH M, et al. Antibodies against carbamylated proteins and cyclic citrullinated pep- tides in systemic lupus erythematosus: results from two well-defined-European cohorts. Arthritis Res Ther; 18:289, 2016.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ricardo Barbosa Filho; Tatiane Bastos Mangueira de Menezes; Pérola Reis de Souza Dias; Emanuelly Thays Muniz Figueiredo Silva; Kristopherson Lustosa; Fabrício André Martins da Costa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.